INS and diabetes mellitus: For the antidiabetic medication of RCM(DM +) patients, 11 patients used insulin, and 40 patients used oral antidiabetic agents (22 for biguanides, 5 for sulfonylureas, 15 for α-Glucosidase inhibitor, and 3 for GLP-1/DPP-4 inhibitor).